dolasetron and Chronic Disease

dolasetron has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bertin, P; Bonnabau, H; Bonnet, C; Dufauret-Lombard, C; Simon, A; Trèves, R; Vergne-Salle, P	1

Trials

1 trial(s) available for dolasetron and Chronic Disease

Article	Year
A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia. European journal of pain (London, England), 2011, Volume: 15, Issue:5 Topics: Adolescent; Adult; Aged; Chronic Disease; Double-Blind Method; Fibromyalgia; Follow-Up Studies; Humans; Indoles; Injections, Intravenous; Middle Aged; Pain; Placebos; Prospective Studies; Quality of Life; Quinolizines; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Young Adult	2011

Article

Year

A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia.

European journal of pain (London, England), 2011, Volume: 15, Issue:5

Topics: Adolescent; Adult; Aged; Chronic Disease; Double-Blind Method; Fibromyalgia; Follow-Up Studies; Humans; Indoles; Injections, Intravenous; Middle Aged; Pain; Placebos; Prospective Studies; Quality of Life; Quinolizines; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Young Adult

2011